Developing new drugs is a costly business. So, too, is paying for the ever more expensive therapies that come to market each year.
Statutorily, neither of those things is the Food and Drug Administration’s problem. But the agency’s new commissioner argues forcefully that the FDA can bring down drug prices for patients — by making life a little easier for Big Pharma.
About the Author Reprints
It is so painful to know that drugs are available but people is unable to have it due to affirdibikity and waiting otherwise to see pain of disease